» Articles » PMID: 2890159

Sequence of an Intestinal CDNA Encoding Human Gastric Inhibitory Polypeptide Precursor

Overview
Specialty Science
Date 1987 Oct 1
PMID 2890159
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Gastric inhibitory polypeptide (GIP) is a 42-amino acid hormone that stimulates insulin secretion in the presence of glucose. Complementary DNA clones encoding human GIP were isolated from a library prepared with RNA from duodenum. The predicted amino acid sequence indicates that GIP is derived by proteolytic processing of a 153-residue precursor, preproGIP. The GIP moiety is flanked by polypeptide segments of 51 and 60 amino acids at its NH2 and COOH termini, respectively. The former includes a signal peptide of about 21 residues and an NH2-terminal propeptide of 30 amino acids. GIP is released from the precursor by processing at single arginine residues. There is a region of nine amino acids in the COOH-terminal propeptide of the GIP precursor that has partial homology with a portion of chromogranin A as well as pancreastatin.

Citing Articles

Pathogenesis of type 2 diabetes in Japan and East Asian populations: Basic and clinical explorations.

Seino Y, Yamazaki Y Proc Jpn Acad Ser B Phys Biol Sci. 2025; 101(2):68-74.

PMID: 39924177 PMC: 11893219. DOI: 10.2183/pjab.101.009.


Physiological Appetite Regulation and Bariatric Surgery.

Ramasamy I J Clin Med. 2024; 13(5).

PMID: 38546831 PMC: 10932430. DOI: 10.3390/jcm13051347.


Mechanisms of action of incretin receptor based dual- and tri-agonists in pancreatic islets.

Folli F, Finzi G, Manfrini R, Galli A, Casiraghi F, Centofanti L Am J Physiol Endocrinol Metab. 2023; 325(5):E595-E609.

PMID: 37729025 PMC: 10874655. DOI: 10.1152/ajpendo.00236.2023.


Tirzepatide: A Novel, Once-weekly Dual GIP and GLP-1 Receptor Agonist for the Treatment of Type 2 Diabetes.

Kaneko S touchREV Endocrinol. 2022; 18(1):10-19.

PMID: 35949358 PMC: 9354517. DOI: 10.17925/EE.2022.18.1.10.


Role of a Dual Glucose-Dependent Insulinotropic Peptide (GIP)/Glucagon-like Peptide-1 Receptor Agonist (Twincretin) in Glycemic Control: From Pathophysiology to Treatment.

Pelle M, Provenzano M, Zaffina I, Pujia R, Giofre F, Luca S Life (Basel). 2022; 12(1).

PMID: 35054422 PMC: 8779403. DOI: 10.3390/life12010029.


References
1.
Brown J, PEDERSON R, JORPES E, Mutt V . Preparation of highly active enterogastrone. Can J Physiol Pharmacol. 1969; 47(1):113-4. DOI: 10.1139/y69-020. View

2.
Tatemoto K, Efendic S, Mutt V, Makk G, Feistner G, Barchas J . Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion. Nature. 1986; 324(6096):476-8. DOI: 10.1038/324476a0. View

3.
PEDERSON R, Brown J . Inhibition of histamine-, pentagastrin-, and insulin-stimulated canine gastric secretion by pure "gastric inhibitory polypeptide". Gastroenterology. 1972; 62(3):393-400. View

4.
Aviv H, Leder P . Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose. Proc Natl Acad Sci U S A. 1972; 69(6):1408-12. PMC: 426713. DOI: 10.1073/pnas.69.6.1408. View

5.
Polak J, Bloom S, Kuzio M, Brown J, Pearse A . Cellular localization of gastric inhibitory polypeptide in the duodenum and jejunum. Gut. 1973; 14(4):284-8. PMC: 1412599. DOI: 10.1136/gut.14.4.284. View